EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $879.51 million. The enterprise value is $553.22 million.
| Market Cap | 879.51M |
| Enterprise Value | 553.22M |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 49.83 million shares outstanding. The number of shares has increased by 4.25% in one year.
| Shares Outstanding | 49.83M |
| Shares Change (YoY) | +4.25% |
| Shares Change (QoQ) | +10.08% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 104.70% |
| Float | 30.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.11 |
| Forward PS | 22.99 |
| PB Ratio | 3.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.45 |
| Quick Ratio | 5.25 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.71 |
Financial Efficiency
Return on equity (ROE) is -61.50% and return on invested capital (ROIC) is -27.68%.
| Return on Equity (ROE) | -61.50% |
| Return on Assets (ROA) | -33.50% |
| Return on Capital (ROIC) | -27.68% |
| Revenue Per Employee | $380,314 |
| Profits Per Employee | -$585,083 |
| Employee Count | 121 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, EYPT has paid $83,000 in taxes.
| Income Tax | 83,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +227.46% in the last 52 weeks. The beta is 1.68, so EYPT's price volatility has been higher than the market average.
| Beta (1Y) | 1.68 |
| 52-Week Price Change | +227.46% |
| 50-Day Moving Average | 23.86 |
| 200-Day Moving Average | 15.99 |
| Relative Strength Index (RSI) | 31.06 |
| Average Volume (30 Days) | 982,382 |
Short Selling Information
The latest short interest is 6.85 million, so 13.74% of the outstanding shares have been sold short.
| Short Interest | 6.85M |
| Short Previous Month | 6.58M |
| Short % of Shares Out | 13.74% |
| Short % of Float | 22.27% |
| Short Ratio (days to cover) | 6.88 |
Income Statement
In the last 12 months, EYPT had revenue of $46.02 million and -$70.80 million in losses. Loss per share was -$1.82.
| Revenue | 46.02M |
| Gross Profit | 41.39M |
| Operating Income | -75.07M |
| Pretax Income | -70.71M |
| Net Income | -70.80M |
| EBITDA | -69.00M |
| EBIT | -69.47M |
| Loss Per Share | -$1.82 |
Balance Sheet
The company has $331.20 million in cash and $4.91 million in debt, giving a net cash position of $326.29 million or $6.55 per share.
| Cash & Cash Equivalents | 331.20M |
| Total Debt | 4.91M |
| Net Cash | 326.29M |
| Net Cash Per Share | $6.55 |
| Equity / Book Value | 266.32M |
| Book Value Per Share | 5.34 |
| Working Capital | 281.54M |
Cash Flow
In the last 12 months, operating cash flow was $1.88 million and capital expenditures -$3.48 million, giving a free cash flow of -$1.61 million.
| Operating Cash Flow | 1.88M |
| Capital Expenditures | -3.48M |
| Free Cash Flow | -1.61M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 89.93%, with operating and profit margins of -163.13% and -153.84%.
| Gross Margin | 89.93% |
| Operating Margin | -163.13% |
| Pretax Margin | -153.66% |
| Profit Margin | -153.84% |
| EBITDA Margin | -149.94% |
| EBIT Margin | -150.95% |
| FCF Margin | -3.49% |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.25% |
| Shareholder Yield | -4.25% |
| Earnings Yield | -8.05% |
| FCF Yield | -0.18% |
Analyst Forecast
The average price target for EYPT is $35.63, which is 101.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.63 |
| Price Target Difference | 101.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 46.19% |
| EPS Growth Forecast (5Y) | -47.67% |
Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
EYPT has an Altman Z-Score of 3.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.45 |
| Piotroski F-Score | 6 |